PULSO | 22-Mar-2017
El Centro Internacional de Arreglo de Diferencias Relativas a Inversiones (CIADI) -organismo del Banco Mundial para el arbitraje de disputas entre inversionistas y estados- falló a favor de Antofagasta plc y Barrick Gold Corp. ante la demanda arbitral presentada contra Pakistán por Tehyan Coopera Company (TCC).
Stock Market Wire | 22-Mar-2017
The ICSID tribunal rejected Pakistan’s final defence against liability and confirmed that Pakistan had violated several provisions of its bilateral investment treaty with Australia
London South East | 22-Mar-2017
Ukranian authorities have now applied to the UK High Court asking to set aside the recent UNCITRAL arbitration award against Ukraine and in favour of JKX.
Tech Dirt | 22-Mar-2017
Just the fact that the Canadian government had to go through this massive and expensive process for many years just for rejecting two bad patents should show why ISDS provisions are such a problem.
Le Soir | 21-Mar-2017
Le Premier ministre japonais Shinzo Abe débarque à Bruxelles. Mais les contestataires critiques partent à l’assaut du projet d’accord avec le Japon.
No al TTIP | 21-Mar-2017
Según el periódico Público, el tratado comercial entre la Unión Europea (UE) y Canadá llegará pronto a las Cortes Generales.
TeleSUR | 21-Mar-2017
Exxon Mobil y Conoco Phillips rechazan el marco legal que rige a Venezuela, en las que PDVSA tiene el 60 por ciento de las acciones y el resto es dispuesto para la participación de transnacionales.
IISD | 21-Mar-2017
Settlements raise threats to principles of good governance, including government accountability, respect for the rule of law, transparency, and respect for citizens’ rights and interests.
IISD | 21-Mar-2017
Les accords de règlement menacent les principes de bonne gouvernance, notamment la redevabilité des gouvernements, le respect de l’état de droit, la transparence et le respect des droits et intérêts des citoyens.
Politico | 20-Mar-2017
Canada has prevailed over pharmaceutical giant Eli Lilly in a long-running investor-state dispute the drug company filed under NAFTA’s investment chapter.